Following its successful contribution to the American Association of Equine Practitioners-led project focused on locomotion ...

At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...

OMRON Healthcare has partnered with Tricog Health to integrate AI-powered ECG analysis into blood pressure monitors, enabling quick risk assessment of heart disease. The service will roll out in India ...

At the 2026 Heart Rhythm Society meeting, researchers presented evidence that AI-powered ECG analysis can detect atrial fibrillation (AF) with over 90% accuracy, even during normal heart rhythm. By ...

This 'dual AI' approach does more than just streamline remote cardiac monitoring workflows; it also reduces alert fatigue by providing clinical teams with highly accurate, trustworthy data. With ...

HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at ...

CAMBRIDGE, Mass., April 08, 2026--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac ...

A new generation of AI-powered ECG analysis is enabling large-scale, real-world cardiac screening in racehorses, while medical leaders urge caution as agentic AI enters healthcare decision-making.

Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...

HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at ...

Collaborates To Advance Next-Gen ECG Solutions. HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at advancing artificial ...